SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5lhq'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QXT_A_MTXA2000_1 (ANTI-METHOTREXATE CDR1-3 GRAFT VHH)	5lhq	CAMELID-DERIVED ANTIBODY FRAGMENT NB7 (Vicugna pacos)	5 / 12	ALA B 24 ARG B 72 ASN B 77 VAL B 79 ALA B 98	None	0.54A	3qxtA-5lhqB: 21.8	3qxtA-5lhqB: 65.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QXT_A_MTXA2000_1 (ANTI-METHOTREXATE CDR1-3 GRAFT VHH)	5lhq	CAMELID-DERIVED ANTIBODY FRAGMENT NB7 (Vicugna pacos)	5 / 12	VAL B 2 ARG B 72 ASN B 77 VAL B 79 ALA B 98	None	0.66A	3qxtA-5lhqB: 21.8	3qxtA-5lhqB: 65.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QXT_B_MTXB2000_1 (ANTI-METHOTREXATE CDR1-3 GRAFT VHH)	5lhq	CAMELID-DERIVED ANTIBODY FRAGMENT NB7 (Vicugna pacos)	7 / 12	VAL B 2 LEU B 4 ALA B 24 ARG B 72 VAL B 79 ALA B 98 TYR B 122	None	0.61A	3qxtB-5lhqB: 22.0	3qxtB-5lhqB: 65.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QXV_A_MTXA2000_1 (ANTI-METHOTREXATE CDR1-4 GRAFT VHH)	5lhq	CAMELID-DERIVED ANTIBODY FRAGMENT NB7 (Vicugna pacos)	7 / 12	VAL B 2 ALA B 24 ARG B 72 ASN B 74 VAL B 79 ALA B 98 TYR B 122	None	0.60A	3qxvA-5lhqB: 21.6	3qxvA-5lhqB: 64.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QXV_B_MTXB2000_1 (ANTI-METHOTREXATE CDR1-4 GRAFT VHH)	5lhq	CAMELID-DERIVED ANTIBODY FRAGMENT NB7 (Vicugna pacos)	6 / 12	VAL B 2 ALA B 24 ARG B 72 VAL B 79 ALA B 98 TYR B 122	None	0.54A	3qxvB-5lhqB: 21.8	3qxvB-5lhqB: 64.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QXV_C_MTXC2000_1 (ANTI-METHOTREXATE CDR1-4 GRAFT VHH)	5lhq	CAMELID-DERIVED ANTIBODY FRAGMENT NB7 (Vicugna pacos)	6 / 11	VAL B 2 ALA B 24 ARG B 72 ASN B 74 VAL B 79 ALA B 98	None	0.57A	3qxvC-5lhqB: 21.9	3qxvC-5lhqB: 64.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QXV_D_MTXD2000_1 (ANTI-METHOTREXATE CDR1-4 GRAFT VHH)	5lhq	CAMELID-DERIVED ANTIBODY FRAGMENT NB7 (Vicugna pacos)	6 / 12	VAL B 2 ALA B 24 ARG B 72 VAL B 79 ALA B 98 TYR B 122	None	0.62A	3qxvD-5lhqB: 21.6	3qxvD-5lhqB: 64.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QXV_E_MTXE2000_1 (ANTI-METHOTREXATE CDR1-4 GRAFT VHH)	5lhq	CAMELID-DERIVED ANTIBODY FRAGMENT NB7 (Vicugna pacos)	5 / 12	ALA B 24 ARG B 72 VAL B 79 ALA B 98 TYR B 122	None	0.51A	3qxvE-5lhqB: 18.1	3qxvE-5lhqB: 64.66

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["3QXT_A_MTXA2000_1","ANTI-METHOTREXATE CDR1-3 GRAFT VHH","5lhq","CAMELID-DERIVED ANTIBODY FRAGMENT NB7","Vicugna pacos",5,"ALA B  24;ARG B  72;ASN B  77;VAL B  79;ALA B  98","None","0.54A","3qxtA-5lhqB:21.8","3qxtA-5lhqB:65.41"],["3QXT_A_MTXA2000_1","ANTI-METHOTREXATE CDR1-3 GRAFT VHH","5lhq","CAMELID-DERIVED ANTIBODY FRAGMENT NB7","Vicugna pacos",5,"VAL B   2;ARG B  72;ASN B  77;VAL B  79;ALA B  98","None","0.66A","3qxtA-5lhqB:21.8","3qxtA-5lhqB:65.41"],["3QXT_B_MTXB2000_1","ANTI-METHOTREXATE CDR1-3 GRAFT VHH","5lhq","CAMELID-DERIVED ANTIBODY FRAGMENT NB7","Vicugna pacos",7,"VAL B   2;LEU B   4;ALA B  24;ARG B  72;VAL B  79;ALA B  98;TYR B 122","None","0.61A","3qxtB-5lhqB:22.0","3qxtB-5lhqB:65.41"],["3QXV_A_MTXA2000_1","ANTI-METHOTREXATE CDR1-4 GRAFT VHH","5lhq","CAMELID-DERIVED ANTIBODY FRAGMENT NB7","Vicugna pacos",7,"VAL B   2;ALA B  24;ARG B  72;ASN B  74;VAL B  79;ALA B  98;TYR B 122","None","0.60A","3qxvA-5lhqB:21.6","3qxvA-5lhqB:64.66"],["3QXV_B_MTXB2000_1","ANTI-METHOTREXATE CDR1-4 GRAFT VHH","5lhq","CAMELID-DERIVED ANTIBODY FRAGMENT NB7","Vicugna pacos",6,"VAL B   2;ALA B  24;ARG B  72;VAL B  79;ALA B  98;TYR B 122","None","0.54A","3qxvB-5lhqB:21.8","3qxvB-5lhqB:64.66"],["3QXV_C_MTXC2000_1","ANTI-METHOTREXATE CDR1-4 GRAFT VHH","5lhq","CAMELID-DERIVED ANTIBODY FRAGMENT NB7","Vicugna pacos",6,"VAL B   2;ALA B  24;ARG B  72;ASN B  74;VAL B  79;ALA B  98","None","0.57A","3qxvC-5lhqB:21.9","3qxvC-5lhqB:64.66"],["3QXV_D_MTXD2000_1","ANTI-METHOTREXATE CDR1-4 GRAFT VHH","5lhq","CAMELID-DERIVED ANTIBODY FRAGMENT NB7","Vicugna pacos",6,"VAL B   2;ALA B  24;ARG B  72;VAL B  79;ALA B  98;TYR B 122","None","0.62A","3qxvD-5lhqB:21.6","3qxvD-5lhqB:64.66"],["3QXV_E_MTXE2000_1","ANTI-METHOTREXATE CDR1-4 GRAFT VHH","5lhq","CAMELID-DERIVED ANTIBODY FRAGMENT NB7","Vicugna pacos",5,"ALA B  24;ARG B  72;VAL B  79;ALA B  98;TYR B 122","None","0.51A","3qxvE-5lhqB:18.1","3qxvE-5lhqB:64.66"]]